8437 (8437) Fair Value & Analysis

Healthcare · Market cap HK$16.7M

8 8437 8437 · HK

PriceHK$0.2500

Fair ValueHK$0.0500

Upside-80.0%

Quality63/100

Watch 8437 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0300 – HK$0.0700

Fair value as of: Jul 3, 2026

From 7 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.1260 – HK$0.4200 · fair‑value band HK$0.0300 – HK$0.0700 · the HK$0.2500 price screens above the HK$0.0500 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8437 (8437) currently trades at HK$0.2500, while our model-based Fair Value estimate is HK$0.0500 — implying the stock looks roughly 80.0% overvalued today. We read business quality at 63/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at HK$2.2M. Revenue declined 58.1% year over year. Net debt stands at HK$3.7M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) HK$2.2M

Revenue growth (YoY) -58.1%

Net margin -228%

Free cash flow HK$113K FY2024

Operating margin -12.1%

EPS (TTM) HK$-0.0100

More key figures

EPS growth (YoY) -66.7%

Net debt HK$3.7M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

8437 reported revenue of HK$5.0M in FY2024 versus HK$7.8M in FY2020, a compound −10.4%/yr. Reported net income was −HK$3.5M in FY2024.

Revenue −10.4%/yr

FY20 HK$7.8M

FY21 HK$238K

FY22 HK$4.2M

FY23 HK$3.2M

FY24 HK$5.0M

Net income

FY20 −HK$9.3M

FY21 −HK$8.8M

FY22 −HK$18.6M

FY23 −HK$6.7M

FY24 −HK$3.5M

Is 8437 fairly valued? → Check now

Similar stocks

6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
HCA Healthcare, Inc H1CA34	R$95.75	R$123.65	+29%
Fresenius SE FSNUY	$11.30	$8.61	-24%
5225 5225	8.67 MYR	3.08 MYR	-64%
IHHHF IHHHF	$1.71	$0.7400	-57%
Tenet Healthcare Corporation THC	$162.06	$282.55	+74%
Rede D'Or São Luiz S.A RDOR3	R$32.76	R$30.33	-7%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8437 (8437) undervalued?

As of Jul 3, 2026, our model estimates a fair value of HK$0.0500 versus a price of HK$0.2500 — about −80% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 8437?

Our model-based fair value for 8437 is HK$0.0500 (as of Jul 3, 2026), built from audited fundamentals. The current price is HK$0.2500.

What is the quality score of 8437?

8437 has a Quality Score of 63/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8437 (8437)?

8437 reported trailing-twelve-month revenue of about HK$2.2M (latest available figure, as of Jul 3, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.